MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 31.03.2026
Omeros Corporation Current Ratio 2011-2026 | OMER
Current Ratio Jährlich Omeros Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 1.87 | 2.41 | 4.12 | 3.75 | 2.29 | 0.497 | 1.25 | 2.65 | 1.37 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.12 | 0.497 | 2.24 |
Current Ratio anderer Aktien in der Pharmaeinzelhändler
| Name | Current Ratio | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.02 | - | 2.43 % | $ 254 M |  Germany |
 |
Advaxis
ADXS
|
5.93 | - | -9.65 % | $ 45.9 M |  USA |
 |
Akouos
AKUS
|
6.18 | - | 0.23 % | $ 488 M | USA |
 |
Allakos
ALLK
|
3.26 | - | - | $ 28.6 M | USA |
 |
AlloVir
ALVR
|
2.84 | - | 4.14 % | $ 49.1 M | USA |
 |
I-Mab
IMAB
|
8.96 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
12.4 | - | - | $ 1.01 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
2.41 | - | -11.43 % | $ 502 K | USA |
 |
Midatech Pharma plc
MTP
|
2.68 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
3.59 | - | - | $ 40.3 B | USA |
 |
Applied Molecular Transport
AMTI
|
2.31 | - | - | $ 10.1 M | USA |
 |
Applied Therapeutics
APLT
|
0.762 | - | - | $ 8.42 M | USA |
 |
Aptorum Group Limited
APM
|
3.81 | $ 0.89 | -0.61 % | $ 6.54 M | China |
 |
Biophytis SA
BPTS
|
1.34 | - | -13.47 % | $ 169 M |  France |
 |
Genfit SA
GNFT
|
0.922 | - | 2.54 % | $ 160 B | France |
 |
ACADIA Pharmaceuticals
ACAD
|
2.61 | $ 22.57 | 1.21 % | $ 3.74 B | USA |
 |
Aptinyx
APTX
|
2.35 | - | -39.0 % | $ 4.57 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.02 | - | -1.52 % | $ 24.7 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
6.43 | - | - | $ 7.46 M |  Israel |
 |
Brainstorm Cell Therapeutics
BCLI
|
0.0929 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
2.37 | - | -4.8 % | $ 255 M | USA |
 |
AIkido Pharma
AIKI
|
2.59 | - | 1.93 % | $ 17.4 M | USA |
 |
Cara Therapeutics
CARA
|
2.88 | - | -3.03 % | $ 260 M | USA |
 |
CASI Pharmaceuticals
CASI
|
4.56 | - | - | $ 35.4 M | USA |
 |
Институт стволовых клеток человека
ISKJ
|
1.04 | - | - | - |  Russia |
 |
ChromaDex Corporation
CDXC
|
3.56 | - | -0.88 % | $ 598 M | USA |
 |
Aeterna Zentaris
AEZS
|
1.22 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
0.995 | - | -10.17 % | $ 12.2 K | USA |
 |
Aravive
ARAV
|
1.21 | - | -13.39 % | $ 1.45 M | USA |
 |
Aridis Pharmaceuticals
ARDS
|
0.378 | - | 17.91 % | $ 11.1 M | USA |
 |
BioNTech SE
BNTX
|
7.95 | $ 101.23 | -0.82 % | $ 27.2 B | Germany |
 |
Checkpoint Therapeutics
CKPT
|
0.372 | - | - | $ 169 M | USA |
 |
Avenue Therapeutics
ATXI
|
2.67 | - | -52.27 % | $ 4.45 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
1.79 | - | - | $ 26.5 M | USA |
 |
Aquestive Therapeutics
AQST
|
0.827 | $ 4.09 | -0.37 % | $ 437 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
1.78 | $ 23.2 | -0.96 % | $ 2.95 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.43 | $ 1.48 | 3.87 % | $ 394 M | Britain |
 |
Aptose Biosciences
APTO
|
0.269 | - | -45.71 % | $ 1.2 M | Canada |
 |
AstraZeneca PLC
AZN
|
1.75 | - | - | $ 96.9 B | Britain |
 |
AVROBIO
AVRO
|
15.9 | - | 1083.1 % | $ 745 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
2.76 | $ 2.9 | -0.64 % | $ 4.77 M | Israel |
 |
BeiGene, Ltd.
BGNE
|
2.14 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Akero Therapeutics
AKRO
|
10.9 | - | - | $ 3.67 B | USA |
 |
bluebird bio
BLUE
|
1.46 | - | - | $ 546 M | USA |
 |
CureVac N.V.
CVAC
|
2.47 | - | - | $ 867 M | Germany |
 |
ContraFect Corporation
CFRX
|
0.636 | - | -5.16 % | $ 5.39 M | USA |
 |
Cardiff Oncology
CRDF
|
3.75 | $ 1.71 | -0.58 % | $ 114 M | USA |
 |
CTI BioPharma Corp.
CTIC
|
0.878 | - | - | $ 1.2 B | USA |
 |
BioXcel Therapeutics
BTAI
|
0.32 | $ 1.07 | -1.83 % | $ 13.1 M | USA |
 |
Cabaletta Bio
CABA
|
3.11 | $ 2.8 | -3.95 % | $ 281 M | USA |